Wolverine Asset Management’s Aimei Health Technology Co AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-401,754
Closed -$4.55M 1653
2025
Q3
$4.55M Sell
401,754
-3,003
-0.7% -$33.8K 0.03% 366
2025
Q2
$4.48M Sell
404,757
-3,042
-0.7% -$33.7K 0.04% 353
2025
Q1
$4.48M Sell
407,799
-246,240
-38% -$2.67M 0.05% 320
2024
Q4
$7M Buy
654,039
+115,000
+21% +$1.22M 0.07% 257
2024
Q3
$5.65M Buy
539,039
+42,843
+9% +$447K 0.06% 280
2024
Q2
$5.14M Buy
496,196
+40,598
+9% +$418K 0.06% 284
2024
Q1
$4.67M Buy
+455,598
New +$4.64M 0.05% 297

Other funds holding AFJK

Wolverine Asset Management's AFJK Position: Q4 2025 in Review

Wolverine Asset Management sold out of Aimei Health Technology Co (AFJK) in Q4 2025, closing a stake of 401,754 shares — an estimated $4.55M sold.

Wolverine Asset Management first reported a position in AFJK in Q1 2024 and held it in 7 quarters. The position peaked at $7M in Q4 2024. 11 funds tracked by Wall St. Rank hold AFJK as of Q4 2025.

  • Wolverine Asset Management reported no remaining Aimei Health Technology Co position as of Q4 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 401,754 Aimei Health Technology Co shares in Q4 2025, an estimated $4.55M.
  • Wolverine Asset Management first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 7 quarters.
  • Wolverine Asset Management's Aimei Health Technology Co position peaked at $7M in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.